Media

News that truly makes a difference

One giant leap for mankind.

We have reached the dawn of a new era in artificial intelligence and machine learning for preclinical and clinical therapeutics development. BullFrog AI is poised to join industry leaders at the forefront of this digital industrial revolution, by leveraging our proprietary bfLEAP™ AI/ML platform for precision development of new medicines. Therapies that will change peoples’ lives. Is there any greater purpose?

PRESS RELEASES:

April 21, 2022

The FSHD Society is deploying powerful AI technology to improve clinical trial design for facioscapulohumeral muscular dystrophy

March 22, 2022

BullFrog AI Enters into Licensing Agreement with Johns Hopkins University for Use of Novel Formulation of Mebendazole for Treatment of Cancer

May 21, 2020

BullFrog AI and TTi Health Research & Economics Announce Partnership

May 7, 2020

BullFrog AI and EastBanc Technologies Seek to Fast-Track Biopharma Clinical Development

April 7, 2020

BullFrog AI Secures $200K from TEDCO’s Seed Fund

February 15, 2018